Search

everythinglearnresearchcommunity

for

Search:↓

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

A new compound was effective for imaging prostate cancer in rats.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

DHHB from Platycladus orientalis L. promotes hair growth and could be a natural alternative to current treatments.

Indian herbs like Bacopa monnieri and Centella asiatica may help memory, but more research is needed.

The article discusses debates on hair transplant techniques, safe donor areas, PRP use, and practitioner qualifications in hair restoration.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Alopecia areata causes patchy hair loss, and certain hair features can suggest its presence.

Trichohyalin is modified by enzymes to form strong structures in hair cells.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

The compounds tested could potentially treat hair loss and alopecia.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Addressing body image and weight can help improve female sexual dysfunction.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.